BrightFocus grantee, Jaehong Suh, Ph.D., of Massachusetts General Hospital and Harvard, is the lead author of this paper and has documented in animal models new disease-causing mutations for Alzheimer’s. These results provide evidence that the ADAM10 gene is a potential therapeutic target for treatment of the late-onset form of this brain disease.
September 25, 2013
Donate to Cure Brain and Eye Diseases
Help end Alzheimer's, Macular Degeneration, and Glaucoma